Jasper Therapeutics, Inc. — DEFA14A Filings
5 DEFA14A filings on record
This page lists all DEFA14A filings submitted to the SEC by Jasper Therapeutics, Inc. (JSPRW), sorted by most recent first. Each row links to the full filing on EdgarLookup. Jasper Therapeutics, Inc. has filed 5 DEFA14A documents with the SEC since 2019. To view all SEC filings by Jasper Therapeutics, Inc., see the full filings list.
All
10-K
10-K/A
10-Q
10-Q/A
144
25-NSE
3
3/A
4
424B3
424B4
424B5
425
8-A12B
8-K
8-K/A
ARS
CERT
CORRESP
DEF 14A
DEFA14A
DRS
EFFECT
NT 10-Q
POS AM
PRE 14A
S-1
S-1/A
S-3
S-4
S-4/A
S-8
S-8 POS
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| DEFA14A | DEFINITIVE ADDITIONAL MATERIALS | 0001213900-25-045090 | May 19, 2025 | — |
| DEFA14A | ADDITIONAL MATERIALS | 0001213900-24-039304 | May 3, 2024 | — |
| DEFA14A | ADDITIONAL MATERIALS | 0001213900-24-034831 | Apr 22, 2024 | — |
| DEFA14A | DEFINITIVE ADDITIONAL MATERIALS | 0001213900-23-031676 | Apr 21, 2023 | — |
| DEFA14A | DEFINITIVE ADDITIONAL MATERIALS | 0001213900-22-022712 | Apr 29, 2022 | — |